In autoimmune diseases responding to TNF neutralisation, sparing TNF/TNFR1 pathway onmyeloid cells, through anti TNF T-cell targeted bi-specific antibodies for instance,should help keeping protection against new exposure to primary, acute TB infection,in patients screened for absence of previous TB exposure. This evidence concerns the gene TNFRSF1A and autoimmune disease.